Avotres
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
140 E Hanover Ave Ste 140, Cedar Knolls,...Phone Number
(908) 591-9796Website
www.avotres.comRevenue
<$5 MillionIndustry
About Avotres
Avotres Org Chart
Is Avotres your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Avotres has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Avotres launches new products
Congratulate Masked Content for being promoted to Masked Content at Avotres
Click to see if Avotres had a recent Job posting/layoffs
Check out if Avotres is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Avotres recently announced quarterly report
Avotres, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Avotres has new funding data
Recommended Actions
Find VP level buyers at Avotres
Find more new buyers
Compare Similar Companies to Avotres
Compare insights from companies similar to Avotres, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avotres is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Avotres is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Avotres.
Avotres Tech Stack
A closer look at the technologies used by Avotres
Avotres News & Media
AVT001 Phase I/II Clinical Trial 1 Year Data in Type 1 Diabetes is Published
From Breakthrough Discovery to Clinical Proof of Concept CEDAR KNOLLS, NJ, USA, June 25, 2024 /EINPresswire.com/ -- Avotres Inc. in collaboration with Joslin Diabetes Center, a Harvard Medical School affiliate, have reported one year data of a phase I/ …Avotres Announces Achieving Primary Endpoint of its Phase 1/2 Clinical Trial of AVT001 in Patients with Type 1 Diabetes
- AVT001 met its primary endpoints (safety) and demonstrated a strong efficacy signal at the primary readout of its phase 1/2 study for Type 1 Diabetes CEDAR KNOLLS, NJ, UNITED STATES, December 9, 2022 /EINPresswire.com/ -- Avotres Inc., a clinical …Avotres Announces Completion of Enrollment of its Phase I/II Trial of AVT001 in Patients with Type 1 Diabetes (T1D)
Avotres Inc. is a clinical stage biotechnology company developing novel immune therapies for autoimmune diseases, cancers, and transplantation CEDAR KNOLLS, NJ, UNITED STATES, December 7, 2021 /EINPresswire.com/ -- Avotres Inc., a clinical stage …Avotres Inc. Has Appointed Dr. Bruce Cooper as Independent Board of Director
CEDAR KNOLLS, NJ, UNITED STATES, August 2, 2021 /EINPresswire.com/ -- Avotres Inc., a clinical stage biotechnology company developing novel immune therapies for autoimmune diseases, cancers, and transplantation, announced today that Dr. Bruce Cooper has …
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avotres
Avotres Inc. is a private biotechnology company focused on developing innovative therapeutic solutions for incurable immunologically mediated disorders. The company aims to address the significant health and economic impact of autoimmune diseases, which affect millions of Americans. With a commitment to advancing science, Avotres Inc. is dedicated... Read More